1 Min Read
March 28 (Reuters) - Promis Neurosciences Inc:
* “our lead development product, pmn310, is on track for ind submission at end of 2018” Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.